GlassScriptPhysician profile
Paul Rogers
NPI 1396735080
$1,618.69
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $278 · 2021: $597.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $581.89 | 2019-2021 | |
| Amgen INC. | $179.97 | 2019 | |
| Therapeuticsmd, INC. | $179.28 | 2019-2021 | |
| Coopersurgical, INC. | $111.72 | 2019 | |
| Eisai INC. | $104.81 | 2019 | |
| Astellas Pharma US INC | $99.95 | 2019 | |
| Myovant Sciences INC. | $95.44 | 2021 | |
| Mylan Pharmaceuticals INC. | $63.96 | 2020-2021 | |
| Avion Pharmaceuticals | $41.72 | 2020-2021 | |
| Lupin INC. | $29.64 | 2019-2020 | |
| Pfizer INC. | $27.29 | 2021 | |
| Sage Therapeutics, LLC | $23.91 | 2021 | |
| Organon LLC | $18.92 | 2021 | |
| Merck Sharp & Dohme LLC | $16.75 | 2020 | |
| Allergan, INC. | $16.67 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $15.65 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.